Publication | Open Access

A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients

Gene Expression SignatureBreast OncologyMedicineCancer GenomicsBreast CancerCancer BiologyTumor SuppressorCancer GeneticsRadiation OncologyOncologyCell BiologyTumor BiologyNeoadjuvant Chemotherapy